Literature DB >> 6087102

Immobilisation hypercalcemia.

R A Evans, M Bridgeman, E Hills, C R Dunstan.   

Abstract

We studied 5 patients with immobilisation hypercalcemia. Plasma calcium was 3.28 +/- (SD) 0.26 mmol/l. Plasma parathyroid hormone (PTH) level was elevated in 3 patients and inappropriately detectable in 1. Nephrogenous cAMP, measured in 3 patients, was low-normal in 1 who had a normal PTH and zero in 2 who had elevated PTH. Quantitative bone histology was performed in 3 patients. 1 had evidence of increased resorption (osteoclast count 7.1/mm2 section area, normal 1.0 +/- 0.5) and had a high-normal bone formation rate. Another had a normal osteoclast count but no evidence of bone formation. The third had normal bone histology. We conclude that (a) the PTH appears to be biologically inactive and its elevation may be due, in some patients, to renal retention of carboxyterminal fragments; (b) the histologic pattern in bone is variable and not predictable from the duration of illness; (c) the mechanism by which immobilisation induces these changes is obscure, and (d) careful clinical assessment may be necessary to avoid misdiagnosing the condition as primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087102

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  6 in total

1.  Acute severe hypercalcemia after traumatic fractures and immobilization in hypophosphatasia complicated by chronic renal failure.

Authors:  Michael P Whyte; Rattana Leelawattana; William R Reinus; Chang Yang; Steven Mumm; Deborah V Novack
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

2.  Immobilization hypercalcaemia due to low bone formation and responding to intravenous sodium sulphate.

Authors:  R A Evans; P J Lawrence; G Thanakrishnan; E Hills; S Y Wong; C R Dunstan
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

3.  Hypercalcemia due to Milk-Alkali Syndrome and Fracture-Induced Immobilization in an Adolescent Boy with Hypoparathyroidism.

Authors:  Rohan K Henry; Rachel I Gafni
Journal:  Horm Res Paediatr       Date:  2016-05-18       Impact factor: 2.852

4.  Hypercalcaemia. What does it signify?

Authors:  R A Evans
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

5.  Hypercalcemia of advanced chronic liver disease: a forgotten clinical entity!

Authors:  Mohammad Shafi Kuchay; Sunil Kumar Mishra; Khalid Jamal Farooqui; Beena Bansal; Jasjeet Singh Wasir; Ambrish Mithal
Journal:  Clin Cases Miner Bone Metab       Date:  2016-05-11

6.  Hypercalcemia in critically ill surgical patients.

Authors:  J Forster; L Querusio; K W Burchard; D S Gann
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.